DYN Dyne Therapeutics, Inc.
Price Chart
Executive Summary
Atlas Venture Opportunity Fund I, L.P., a major venture investor, filed a Form 144 indicating intent to sell 2,466 shares of Dyne Therapeutics, with an estimated value of approximately $42,884. The proposed sale is tiny relative to Dyne's $2.9B market cap and appears to be routine portfolio rebalancing. However, the filing comes amid a cluster of 9 insider sales totaling $8.6M over the past 30 days, which merits attention.
Actionable Insight
This filing alone is not material. However, the broader pattern of elevated insider selling (9 transactions, $8.6M over 30 days) warrants monitoring for potential negative sentiment. Watch for any material adverse news or guidance changes in upcoming filings.
Key Facts
- Filing by Atlas Venture Opportunity Fund I, L.P., a VC fund, not an officer/director.
- Proposed sale of 2,466 shares of Dyna Therapeutics common stock.
- Estimated market value of ~$42,884 (based on current price).
- Filing date: 2026-05-04.
- Proposed sale represents ~0.0015% of market cap (negligible).
- Recent insider selling cluster: 9 sales totaling $8.6M in the last 30 days.
Financial Impact
Negligible; proposed sale value of ~$42,884 is minimal relative to ~$2.9B market cap.
Risk Factors
- Insider selling cluster may indicate negative outlook, but this specific filing is too small to be a signal.
- Venture fund sale could be routine liquidity event, not necessarily informed selling.
Market Snapshot
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 144 Filing (Primary) | 0001628280-26-029910 |
| Document: 0001628280-26-029910-index.html | 0001628280-26-029910 |
| Document: 0001628280-26-029910.txt | 0001628280-26-029910 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
|
May 20, 2026
3d ago
|
Press Release
| $17.60 awaiting T+5 | awaiting T+5 | — | $17.37 (−1.31%) |
|
May 20, 2026
3d ago
|
Press Release
| — | awaiting T+5 | — | — |
|
May 13, 2026
10d ago
|
144
| — | awaiting T+5 | — | — |
|
May 13, 2026
10d ago
|
144
| — | awaiting T+5 | — | — |
|
May 11, 2026
12d ago
|
8-K
| $18.46 $16.54 | ▼ −10.40% | ▼ −10.32% | $17.37 (−5.90%) |
|
May 6, 2026
17d ago
|
144
| $17.54 $18.44 | ▲ +5.13% | ▲ +3.63% | $17.37 (−0.97%) |
|
May 6, 2026
17d ago
|
144
| $17.54 $18.44 | ▲ +5.13% | ▲ +3.63% | $17.37 (−0.97%) |
|
May 4, 2026
19d ago
|
144
| $17.47 $18.37 | ▲ +5.15% | ▲ +3.17% | $17.37 (−0.57%) |
|
May 4, 2026
19d ago
|
144
| $17.47 $18.37 | ▲ +5.15% | ▲ +3.17% | $17.37 (−0.57%) |
|
May 4, 2026
19d ago
|
144
| $17.47 $18.37 | ▲ +5.15% | ▲ +3.17% | $17.37 (−0.57%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access